Microbiome Times Partnering Forum
Brussels, Belgium , 18 - 19 Mar 2025
We are looking forward to supporting the Microbiome Times Partnering Forum in March 2025 where we will be speaking and exhibiting. This two-day event will explore the industry’s latest trends, challenges, and opportunities to accelerate the development of novel microbial-based solutions to pressing challenges with over 50 expert speakers.
Dr Elizabeth Crone, Head of Business Development, Research Products and Services Europe will be presenting the below talk:
‘Analyzing Microbiome Metabolites with Non-Invasive Breath Samples.’
If you are interested in learning more about the work Owlstone Medical is doing, please get in touch to meet with us at the conference.
Meet the Team:
Dr Elizabeth Crone
Liz who is Head of Business Development, Research Products and Services Europe, will be attending the event. She has a strong technical background, with a biochemistry degree from Leeds University and a PhD from the University of Cambridge in biophysical chemistry, as well as several years consulting experience on technical innovation projects for companies like J&J, P&G and Shell. For the last decade, she has focussed on her passion: helping companies with potentially life-changing innovative technologies bring them to where they can be most useful. Liz now works in Owlstone, liaising with European-based companies and leading academics to help them explore and utilize breath as a biomarker matrix to advance their research.
Dr Ben Constant
Dr Ben Constant is a Business Development Executive at Owlstone Medical, where he is dedicated to advancing breath biomarker research.
Ben completed his undergraduate studies in Biomedical Sciences at the University of Sheffield, before pursuing a PhD at the University of Cambridge under the supervision of Dr Wei Li in the Department of Medicine. His doctoral research focused on elucidating the mechanisms of action of a novel pharmaceutical treatment for obesity.
Ben has a diverse background in the medical technology sector. He previously worked at Ortho Clinical Diagnostics, where he contributed to the development of a diagnostic test for heart attacks. Additionally, he has served as a technical consultant, assisting MedTech innovators in bringing their cutting-edge technologies to market.
In his current role, Ben is passionate about collaborating with leading scientists across Europe and Asia, helping them explore how breath biomarkers can enhance their research and clinical outcomes.
